Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to investigate whether 2 different tablet compositions are similar regarding absorption (uptake) in the body. One composition was used in the clinical development program and the other is intended for the market


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Bio-equivalence Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT02894515
Study type Interventional
Source H. Lundbeck A/S
Contact
Status Withdrawn
Phase Phase 1
Start date September 2016
Completion date September 2016

See also
  Status Clinical Trial Phase
Completed NCT03018015 - Ibuprofen Bioavailability Trial With Oral Single Dose Administration. Phase 1
Completed NCT02206295 - Study in Healthy Male Subjects to Demonstrate Bioequivalence of 1600 μg Selexipag Administered as Eight Tablets of 200 μg or as Single Tablet of 1600 μg Phase 1
Completed NCT01331993 - A Bioequivalence Study to Compare VIMOVO Manufactured at AstraZenca AB to VIMOVO Manufactured by Patheon Pharmaceuticals and Marketed Enteric-coated Naproxen Formulation Phase 1
Completed NCT01260805 - A Bioequivalence Study Of Ethinylestradiol + Gestodene In Female And Healthy Volunteers. Phase 1
Recruiting NCT03340753 - Bioavailability of KBP-5074 Tablet vs Capsule Formulations Phase 1
Enrolling by invitation NCT03337126 - Bioavailability of ATI-1501 With Taste Test Sub Study Phase 1
Recruiting NCT02341274 - Effects of Altered Formulation on the Bioequivalence of Tacrolimus in Healthy Female and Male Volunteeers Phase 1
Completed NCT01638143 - Bio-equivalence Study N/A
Active, not recruiting NCT03420534 - Human Bioequivalence Test (Fasting & Postprandial) of Iloperidone Tablets Phase 1
Recruiting NCT03232710 - Bioequivalence Study of Bosiqing and ABILIFY Under Fasting/Fed Condition N/A
Completed NCT02436577 - Study to Assess the Bioequivalence Between Ticagrelor Orodispersible Tablets and Ticagrelor Immediate-release Tablets in Japanese Subjects Phase 1
Completed NCT03452306 - Bioequivalence Study of Metformin 750 mg Tablets XR Versus Glucophage® Long 750 mg Tablets XR In Normal Healthy Subjects Under Fasting and Fed Conditions Phase 1
Completed NCT03213353 - A Bioequivalence Study Between Two Brands of Medications to Treat Cough & Cold Symptoms N/A
Completed NCT02071589 - Bioavailability Of A Single Dose Of Nifedipine Oral Solution Compared To Adalat Capsules In Healthy Female Volunteers Phase 1
Active, not recruiting NCT03015259 - Randomized, Placebo-controlled, Multi-dose, Study Comparing Budesonide/Formoterol to Symbicort® in Asthmatic Patients Phase 3
Completed NCT03424928 - A Pilot Bioequivalence Study of Pomalidomide Phase 1
Completed NCT02385851 - Comparison of the Pharmacokinetic and Pharmacodynamic Biosimilarity of CHS-1701 (Coherus Pegfilgrastim) With Neulasta® (Pegfilgrastim) Phase 1
Completed NCT02592031 - Study to Compare the Bioavailability, Safety and Tolerability of XM17 in Healthy, Down Regulated Young Women Phase 1
Completed NCT03458208 - Bioequivalence Study of Metformin 1000 mg Tablets IR Versus Glucophage® 1000 mg Tablets IR In Normal Healthy Subjects Under Fasting and Fed Conditions Phase 1
Completed NCT03273088 - Pharmacokinetic, Safety and Tolerability Study of Altebrel in Healthy Male Subjects Phase 1